← Leaderboards
Bjorn E Oskarsson
Mayo Clinic Jacksonville
$14,441,633
Attributed
$14,441,633
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.6M · FY2020–25$10M$7.5M$5M$2.5M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,441,633 · 2
By mechanism
U01$11,846,278 · 1
P01$2,595,355 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Jacksonville
Same institution · by research overlap
- Leonard Petrucelli$43,938,031
- Tania France Gendron$4,632,093
- Marka Van Blitterswijk$6,748,882
- Mark T W Ebbert$5,486,630
- Yongjie Zhang$2,227,470
Others in their field
Other Emerging Leaders on “Visit”
- Kimberly Smith · Ppd Development Lp$115,671,664
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn$36,963,472
- Michelle Lynn Sever · Rho Federal Systems Division, Inc.$26,732,375
- Abraham Aizer Brody · New York University School Of Medicine$24,770,325
- Xinhua Li · Nano Terra, Inc.$23,903,965
Research focus
VisitClinicLifeSiteNeurodegenerative DisordersGenesEvaluationGeneticParticipantSamplingResourcesPathway InteractionsBiological MarkersAmyotrophic Lateral SclerosisAls PatientsBloodBiomarker DiscoveryAnimalsBiologicalDatabasesData CollectionDefectAffectCatalogs
Grant awards (7)
Scalable Expanded Access with Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS (SEA-NOBI-ALS)$5,712,981
U01 · FY2025 · NS · contact PI
Scalable Expanded Access with Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS (SEA-NOBI-ALS)$6,133,297
U01 · FY2024 · NS · contact PI
Core B$511,433
P01 · FY2024 · NS · contact PI
Core B$515,903
P01 · FY2023 · NS · contact PI
Core B$486,767
P01 · FY2022 · NS · contact PI
Core B$524,455
P01 · FY2021 · NS · contact PI
Core B$556,797
P01 · FY2020 · NS · contact PI